National Healthcare Properties, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that National Healthcare Properties, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $342.28M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $353.79M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $345.93M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $335.85M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $329.36M | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | $90.88M | Mar 30, 2021 |
| FY2020 | Sep 30, 2020 | $95.84M | Mar 30, 2021 |
| FY2020 | Jun 30, 2020 | $94.66M | Mar 30, 2021 |
| FY2020 | Mar 31, 2020 | $100.24M | Mar 30, 2021 |
| FY2020 | Dec 31, 2019 | $94.47M | Mar 30, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.38M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $132.34M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $128.13M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $122.40M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $123.54M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $138.06M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $140.73M | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | $141.41M | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | $124.90M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $130.49M | Mar 14, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | ($20.73M) | Mar 30, 2021 |
| FY2020 | Sep 30, 2020 | ($10.50M) | Mar 30, 2021 |
| FY2020 | Jun 30, 2020 | ($22.81M) | Mar 30, 2021 |
| FY2020 | Mar 31, 2020 | ($24.74M) | Mar 30, 2021 |
| FY2020 | Dec 31, 2019 | ($48.13M) | Mar 30, 2021 |
| FY2020 | Sep 30, 2019 | ($28.79M) | Mar 30, 2021 |
| FY2020 | Jun 30, 2019 | ($6.05M) | Mar 30, 2021 |
| FY2020 | Mar 31, 2019 | ($5.11M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($10.24M) | Mar 24, 2020 |
| FY2019 | Sep 30, 2018 | ($29.61M) | Mar 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.30M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($123.54M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | ($4.74M) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | ($31.54M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($37.44M) | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($19.87M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | ($31.79M) | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | ($3.18M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | ($12.22M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | ($3.31M) | Mar 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.95M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($79.85M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $21.62M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $28.30M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $38.88M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $41.81M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $47.40M | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | $54.15M | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | $63.97M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $78.73M | Mar 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $16.72M | Mar 24, 2020 |
| FY2019 | Dec 31, 2018 | $12.91M | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | $8.28M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $7.48M | Mar 14, 2019 |
| FY2017 | Dec 31, 2015 | $6.89M | Mar 20, 2018 |
| FY2016 | Dec 31, 2014 | $807.0K | Mar 21, 2017 |
| FY2015 | Dec 31, 2013 | $0 | Mar 11, 2016 |
| FY2014 | Dec 31, 2012 | $0 | Apr 15, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.95B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.15B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.18B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.21B | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.29B | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | $2.33B | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $2.38B | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.37B | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.19B | Mar 20, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.26B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.24B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.18B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.17B | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.33B | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.22B | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $1.14B | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.02B | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $689.38M | Mar 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $600.06M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $684.56M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $894.15M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $992.64M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.03B | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $956.99M | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.10B | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $1.23B | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.35B | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.50B | Mar 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($1.46B) | Mar 17, 2023 |
| FY2022 | Dec 31, 2021 | ($1.28B) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.11B) | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | ($971.19M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($804.33M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($665.03M) | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | ($486.57M) | Mar 20, 2018 |
| FY2016 | Dec 31, 2015 | ($316.28M) | Mar 21, 2017 |
| FY2015 | Dec 31, 2014 | ($129.41M) | Mar 11, 2016 |
| FY2014 | Dec 31, 2013 | ($3.88M) | Apr 15, 2015 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.62M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $21.65M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $46.41M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $53.65M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $59.74M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $72.36M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $95.69M | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | $77.26M | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | $94.18M | Mar 24, 2020 |
| FY2017 | Dec 31, 2016 | $29.23M | Mar 20, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | (7) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 18, 2022 |
| FY2014 | Dec 31, 2014 | 0 | Apr 15, 2015 |
| FY2014 | Sep 30, 2014 | 0 | Apr 15, 2015 |
| FY2014 | Jun 30, 2014 | 0 | Apr 15, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | (7) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 18, 2022 |
| FY2015 | Dec 31, 2013 | 0 | Mar 11, 2016 |
| FY2015 | Sep 30, 2013 | 0 | Mar 11, 2016 |
| FY2015 | Jun 30, 2013 | 0 | Mar 11, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.43M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 28.30M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 27.89M | Feb 27, 2025 |
| FY2024 | Dec 31, 2022 | 26.27M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 99.28M | Mar 15, 2024 |
| FY2021 | Dec 31, 2020 | 93.78M | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | 92.36M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | 91.96M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 91.00M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | 89.37M | Mar 20, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 17, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Mar 17, 2023 |
| FY2022 | Dec 31, 2020 | $31.35M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $51.43M | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | $55.33M | Mar 30, 2021 |